
Medical schemes push ahead with case over Covid test pricing
The Competition Tribunal has dismissed key objections from major pathology laboratories, moving the medical schemes closer to having their damages claim heard in the High Court.
The Competition Tribunal has dismissed key objections from major pathology laboratories, moving the medical schemes closer to having their damages claim heard in the High Court.
The change is aimed at making the financial information of insurers more easily comparable across countries and industries.
Solidarity and AfriForum are the first out of the starting blocks with legal challenges to the NHI Act.
Notifications